Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)
Trial ID or NCT#
NCT00402740
Status
NOT RECRUITING
Purpose
The purpose of this study is to evaluate the long-term safety and efficacy of the Xact™ Rapid Exchange Carotid Stent System used in conjunction with the Emboshield® Pro Rapid Exchange Embolic Protection System (Generation 5) and the Emboshield® BareWire™ Rapid Exchange Embolic Protection System (Generation 3), in the treatment of atherosclerotic carotid artery disease in high-surgical risk subjects.
Official Title
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Neil Schwartz, MD, PhD
Stroke and vascular neurologist,
General neurologist
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), Neurosurgery
Huy M. Do, MD
Interventional neuroradiologist,
Radiologist
Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Neurosurgery and of Otolaryngology - Head & Neck Surgery (OHNS)
Contact us to find out if this trial is right for you.
Contact
Ronald Dalman
(650) 725-5227
View on ClinicalTrials.gov